Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

This publication has 20 references indexed in Scilit:

• Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
  International Journal of Cancer, 2007
• Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer
  British Journal of Cancer, 2007
• Highly Effective Detection of Human Papillomavirus 16 and 18 DNA by a Testing Algorithm Combining Broad-Spectrum and Type-Specific PCR
  Journal of Clinical Microbiology, 2006
• Cumulative 5‐year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high‐risk HPV and cytology testing in a primary screening setting
  International Journal of Cancer, 2005
• Human papillomavirus type specific DNA and RNA persistence—implications for cervical disease progression and monitoring
  Journal of Medical Virology, 2004
• Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
  New England Journal of Medicine, 2003
• Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study
  BMJ, 2002
• Identification of Two Cross-Neutralizing Linear Epitopes within the L1 Major Capsid Protein of Human Papillomaviruses
  Journal of Virology, 2002
• Type-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical Cancer
  New England Journal of Medicine, 1999
• Characterization of Events during the Late Stages of HPV16 Infectionin VivoUsing High-Affinity Synthetic Fabs to E4
  Virology, 1997